Amgen invests $650 million on expansion of US manufacturing network
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Subscribe To Our Newsletter & Stay Updated